MOR Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

MOR Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+1,910	New	+$207K	0.09%	116

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

MOR Wealth Management's PJP Position: Q2 2026 in Review

MOR Wealth Management opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 1,910 shares worth $226K. The stake represents 0.09% of the portfolio and ranks #116 among its holdings.

117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

MOR Wealth Management held 1,910 shares of Invesco Pharmaceuticals ETF worth $226K as of Q2 2026.
Invesco Pharmaceuticals ETF was a new MOR Wealth Management position in Q2 2026.
Invesco Pharmaceuticals ETF made up 0.09% of MOR Wealth Management's portfolio in Q2 2026, its #116 holding.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on MOR Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.